Thursday, September 29, 2016 7:06:42 AM
I didn't just come to these conclusions randomly one day. I was doing proper DD on a stock I was interested in buying. I have no doubt this stock will go up and down many times before Rexista decision is a done deal. Plenty of money to be made here if that's the game you play. But I look for long term fundamentals, and those are weak here. No public HAL studies for Rexista says all I need to know. With Rexista unlikely to get approval with current formulation, there is nothing for PODRAS to enhance, even if future IPCI engineers can get it to work. Generics are a joke- still waiting to hear about Focalin from their partner that no longer exists. Keppra languishes. Most pending ANDA's are late to well-established markets.
Catalysts for this company tend to be rumors on twitter. Not my kind of investment.
Historic note: Until his life's destiny was further clarified, Robin Hood spent several years robbing from the rich and giving to the porcupines. (G. Larson 7/26/82)
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM